RxDoctor Payments Data

Robert Chua, MD

Family Medicine · Jensen Beach, FLNPI 1245215375

Payments from drug & device makers

$2,703in general payments, 2019–2025

Across 139 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$383
  • Astellas Pharma US Inc$247
  • Lilly USA, LLC$243
  • Pfizer$231
  • Novartis$217
  • Amgen$191
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,48492%
  • Education$1756%
  • Other$442%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,703 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$92,012
Medicare patients
399
Services billed
1,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide133$149,202
EliquisApixaban119$115,884
JardianceEmpagliflozin71$85,810
MounjaroTirzepatide32$50,589
XareltoRivaroxaban40$46,961
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$29,333
TrulicityDulaglutide24$24,617
WegovySemaglutide15$22,515
JanuviaSitagliptin Phosphate16$18,205
Stiolto RespimatTiotropium Br/Olodaterol Hcl16$10,441
NexlizetBempedoic Acid/Ezetimibe16$8,599
SymbicortBudesonide/Formoterol Fumarate19$7,934
Tresiba Flextouch U-100Insulin Degludec11$7,673
BelsomraSuvorexant15$6,366
Albuterol Sulfate HfaAlbuterol Sulfate103$3,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$383$171,716148 claims
PfizerEliquis$231$115,884119 claims
Boehringer IngelheimJardiance, Stiolto Respimat$69$96,25087 claims
Lilly USA, LLCMounjaro, Trulicity$243$75,20656 claims
Johnson & JohnsonXarelto$40$46,96140 claims
GSKTrelegy Ellipta$180$29,33325 claims
MerckJanuvia, Belsomra$83$24,57131 claims
AstraZenecaSymbicort$125$7,93419 claims
AbbVieSynthroid$148$1,79934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jensen Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →